Physician profile
Alan Katz
NPI 1861489023
$3,418.07
in general payments reported to CMS, 2019-2025
19 companies · $691 in 2025
The $691 reported for 2025 was more than what 79% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $357 · 2021: $664 · 2022: $821 · 2023: $257 · 2024: $235 · 2025: $691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,183.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $882.06 | 2019-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $845.87 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $408.74 | 2019-2025 | Jardiance, Ofev, Tradjenta |
| Lilly USA, LLC | $276.61 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $242.72 | 2024-2025 | Airsupra, Breztri |
| Cvrx, INC. | $179.74 | 2025 | Barostim Neo System |
| Abbvie INC. | $150.22 | 2021-2025 | |
| Glaxosmithkline, LLC. | $96.42 | 2021-2023 | Shingrix, Arexvy |
| Medtronic, INC. | $42.17 | 2025 | Intellis Adaptivestim, Inceptiv |
| Abbott Laboratories | $38.83 | 2023-2024 | Proclaim, Freestyle Libre 3 |
| Amgen INC. | $38.14 | 2022 | |
| Novartis Pharmaceuticals Corporation | $37.88 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.34 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.92 | 2022 | |
| Pfizer INC. | $30.01 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $27.79 | 2025 | The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company Ltd. | $23.81 | 2022 | |
| Insmed, INC. | $15.44 | 2025 | Arikayce |
| Philips North America LLC | $15.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.